The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review.
BACKGROUND
Numerous studies were performed to illuminate mechanisms of tumorigenesis and metastases from gene expression profiles of Head and Neck Squamous Cell Carcinoma (HNSCC). The objective of this review is to conduct a network-based meta-analysis to identify the underlying biological signatures of the HNSCC transcriptome.


RESULTS
We included 63 HNSCC transcriptomic studies into three specific categories of comparisons: Pre, premalignant lesions v.s. normal; TvN, primary tumors v.s. normal; and Meta, metastatic or invasive v.s. primary tumors. Reported genes extracted from the literature were systematically analyzed. Participation of differential gene activities across three progressive stages deciphered the evolving nature of HNSCC. In total, 1442 genes were verified, i.e. reported at least twice, with ECM1, EMP1, CXCL10 and POSTN shown to be highly reported across all three stages. Knowledge-based networks of the HNSCC transcriptome were constructed, demonstrating integrin signaling and antigen presentation pathways as highly enriched. Notably, functional estimates derived from topological characteristics of integrin signaling networks identified such important genes as ITGA3 and ITGA5, which were supported by findings of invasiveness in vitro. Moreover, we computed genome-wide probabilities of reporting differential gene activities for the Pre, TvN, and Meta stages, respectively. Results highlighted chromosomal regions of 6p21, 19p13 and 19q13, where genomic alterations were shown to be correlated with the nodal status of HNSCC.


CONCLUSIONS
By means of a systems-biology approach via network-based meta-analyses, we provided a deeper insight into the evolving nature of the HNSCC transcriptome. Enriched canonical signaling pathways, hot-spots of transcriptional profiles across the genome, as well as topologically significant genes derived from network analyses were highlighted for each of the three progressive stages, Pre, TvN, and Meta, respectively.
Yu
Yau-Hua
YH
School of Dentistry, National Yang-Ming University, Taipei, Taiwan. yauhuayu@gmail.com
Kuo
Hsu-Ko
HK
Chang
Kuo-Wei
KW
D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D019295:Computational Biology / Q000379:methods; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic; D015894:Genome, Human; D006258:Head and Neck Neoplasms / Q000378:metabolism*; D006801:Humans; D016023:Integrins / Q000378:metabolism; D008957:Models, Genetic; D015233:Models, Statistical; D009362:Neoplasm Metastasis; D020411:Oligonucleotide Array Sequence Analysis; D015398:Signal Transduction; D049490:Systems Biology
D016023:Integrins
Nature. 2007 Dec 6;450(7171):903-7
18026089
Nature. 2005 Feb 24;433(7028):895-900
15729348
Nat Cell Biol. 2007 Dec;9(12):1392-400
18037882
Lancet. 1999 Nov 27;354(9193):1896-900
10584742
Genome Biol. 2006;7(12):R117
17156469
JAMA. 2007 Jan 10;297(2):187-95
17213402
Genome Res. 2003 Nov;13(11):2498-504
14597658
Nat Biotechnol. 2007 May;25(5):547-54
17483841
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Nat Cell Biol. 2007 Aug;9(8):858-67
17671451
Nature. 2004 Jul 1;430(6995):88-93
15190252
Nat Clin Pract Oncol. 2007 Mar;4(3):156-71
17327856
Mol Syst Biol. 2007;3:87
17353929
Cancer. 2005 Sep 15;104(6):1113-28
16092115
Nat Genet. 2005 Jun;37 Suppl:S38-45
15920529
Cancer Cell. 2004 May;5(5):489-500
15144956
Nature. 2005 Oct 13;437(7061):1032-7
16136080
Int J Cancer. 2003 Sep 20;106(5):683-9
12866027
Clin Cancer Res. 2007 May 15;13(10):2905-15
17504990
Nat Genet. 2007 Nov;39(11):1338-49
17922014
Genome Biol. 2003;4(5):P3
12734009